Atlas Trials

A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects

Clinical trial NCT05108350 · UNKNOWN

Trial details

NCT number
NCT05108350
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Type II Diabetes
Start date
2021-11-09
Primary completion
2021-12-03
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.